Grant: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Primary Recipient
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Amount
$769,386.00
Award Date
7/16/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
This project will characterize the role of the ubiquitin ligase RNF5 in ER stress response in breast cancer and melanoma tumors, where its expression is elevated. Our preliminary results established a novel link between RNF5, ER stress and key phenotypes
Vendors Connected to Award
Vendor | Role | Amount |
---|---|---|
American Type Culture Collections | Primary vendor | $1,366.95 |
GE Healthcare Bio-Sciences Corp | Primary vendor | $263.18 |
Applied Biosystems | Primary vendor | $2,496.42 |
BD Biosciences | Primary vendor | $1,514.96 |
Bio-Rad Laboratories | Primary vendor | $2,969.67 |
Roche Diagnostics Corp | Primary vendor | $3,945.61 |
Lonza Walkersville Inc | Primary vendor | $2,129.40 |
TW Medical | Primary vendor | $132.58 |
Dako North America Inc | Primary vendor | $1,903.26 |
OfficeMax A Boise Company | Primary vendor | $181.60 |
Fisher Scientific Company LLC | Primary vendor | $23,409.35 |